Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 37KL2 | IM / LA |
Reported Symptoms: 10015218:ERYTHEMA MULTIFORME; 10037844:RASH; 10053425:INJECTION SITE SWELLING; Narrative: Patient presented to ED for evaluation of local reaction in 2018. Per ED, could also have other cause such as bug bite. Patient was later given the 2nd Shingrix dose in 2019 appears to have tolerated. Other Relevant HX: Other: Swelling at injection site